FAIRMOUNT FUNDS MANAGEMENT LLC enters ALAUNOS THERAPEUTICS, INC. with 687.79K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 10/15/2026ACC: 0001683168-26-007900
Director10% Owner
Since Oct 2026
687.79K
Baseline shares
0.00
Direct ownership
0 positions
174.25M
Derivative underlying
3 instruments
1
Security positions
687.79K indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned687.79K
Total
687.79K indirect687.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 687.79K | Indirect |
| Total | 687.79K | 687.79K indirect |
Derivative Holdings3
Series C Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
52.24M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series B Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
105.29M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series C Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
16.73M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
174.25M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series C Preferred Stock Indirect | Common Stock | — | — | 52.24M | N/A | |
| Series B Preferred Stock Indirect | Common Stock | — | — | 105.29M | N/A | |
| Series C Preferred Stock Indirect | Common Stock | — | — | 16.73M | N/A | |
| Total | 174.25M | 0.00 | ||||